Sanofi (SNYNF) Gets a Hold Rating from Berenberg Bank


In a report issued on September 28, Berenberg Bank from Berenberg Bank maintained a Hold rating on Sanofi (SNYNF), with a price target of EUR92.00. The company’s shares closed last Tuesday at $100.79.

Currently, the analyst consensus on Sanofi is a Moderate Buy with an average price target of $120.31.

See today’s analyst top recommended stocks >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.

Read More on SNYNF:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts